FDA — authorised 3 October 2013
- Application: NDA022247
- Marketing authorisation holder: WYETH PHARMS
- Local brand name: DUAVEE
- Indication: TABLET — ORAL
- Status: approved
🇺🇸 Duavee in United States
FDA authorised Duavee on 3 October 2013
Marketing authorisation
Duavee in other countries
Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.
Other Bone approved in United States
Frequently asked questions
Is Duavee approved in United States?
Yes. FDA authorised it on 3 October 2013.
Who is the marketing authorisation holder for Duavee in United States?
WYETH PHARMS holds the US marketing authorisation.